# Inflammatory Myopathies and Dermatomyositis

**Type:** Topics  
**Canonical URL:** https://scholariq.org/topics/inflammatory-myopathies-and-dermatomyositis/

## Facts

| Field | Value |
| --- | --- |
| Description | This cluster of papers covers the epidemiology, classification, and clinical features of inflammatory myopathies such as dermatomyositis and polymyositis. It includes discussions on autoantibodies, interstitial lung disease, cancer risk, treatment strategies, myositis-specific antibodies, juvenile dermatomyositis, and the association with malignancy. |
| Domain | Health Sciences |
| Field | Medicine |
| OpenAlex ID | t11724 |
| Works | 126 |

## Topic papers all

Showing 15 of 126.

- [2017 European League Against Rheumatism/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups](https://scholariq.org/papers/2017-european-league-against-rheumatism-american-college-of-rheumatology/)
- [Statin-associated muscle symptoms: impact on statin therapy—European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and Management](https://scholariq.org/papers/statin-associated-muscle-symptoms-impact-on-statin-therapy-european/)
- [Frequency of specific cancer types in dermatomyositis and polymyositis: a population-based study](https://scholariq.org/papers/frequency-of-specific-cancer-types-in-dermatomyositis-and-polymyositis-a/)
- [An official European Respiratory Society/American Thoracic Society research statement: interstitial pneumonia with autoimmune features](https://scholariq.org/papers/an-official-european-respiratory-society-american-thoracic-society-research/)
- [Prognostic Significance of Histopathologic Subsets in Idiopathic Pulmonary Fibrosis](https://scholariq.org/papers/prognostic-significance-of-histopathologic-subsets-in-idiopathic-pulmonary/)
- [Incidence and mortality of interstitial lung disease in rheumatoid arthritis: A population‐based study](https://scholariq.org/papers/incidence-and-mortality-of-interstitial-lung-disease-in-rheumatoid-arthritis-a/)
- [2017 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Adult and Juvenile Idiopathic Inflammatory Myopathies and Their Major Subgroups](https://scholariq.org/papers/2017-european-league-against-rheumatism-american-college-of-rheumatology-2/)
- [Polymyositis–Dermatomyositis-associated Interstitial Lung Disease](https://scholariq.org/papers/polymyositis-dermatomyositis-associated-interstitial-lung-disease/)
- [224th ENMC International Workshop:](https://scholariq.org/papers/224th-enmc-international-workshop/)
- [New-onset IgG autoantibodies in hospitalized patients with COVID-19](https://scholariq.org/papers/new-onset-igg-autoantibodies-in-hospitalized-patients-with-covid-19/)
- [Proteome-wide Analysis and CXCL4 as a Biomarker in Systemic Sclerosis](https://scholariq.org/papers/proteome-wide-analysis-and-cxcl4-as-a-biomarker-in-systemic-sclerosis/)
- [Measures of adult and juvenile dermatomyositis, polymyositis, and inclusion body myositis: Physician and Patient/Parent Global Activity, Manual Muscle Testing (MMT), Health Assessment Questionnaire (HAQ)/Childhood Health Assessment Questionnaire (C‐HAQ), Childhood Myositis Assessment Scale (CMAS), Myositis Disease Activity Assessment Tool (MDAAT), Disease Activity Score (DAS), Short Form 36 (SF‐36), Child Health Questionnaire (CHQ), Physician Global Damage, Myositis Damage Index (MDI), Quantitative Muscle Testing (QMT), Myositis Functional Index‐2 (FI‐2), Myositis Activities Profile (MAP), Inclusion Body Myositis Functional Rating Scale (IBMFRS), Cutaneous Dermatomyositis Disease Area and Severity Index (CDASI), Cutaneous Assessment Tool (CAT), Dermatomyositis Skin Severity Index (DSSI), Skindex, and Dermatology Life Quality Index (DLQI)](https://scholariq.org/papers/measures-of-adult-and-juvenile-dermatomyositis-polymyositis-and-inclusion-body/)
- [Classification of antineutrophil cytoplasmic autoantibody vasculitides: The role of antineutrophil cytoplasmic autoantibody specificity for myeloperoxidase or proteinase 3 in disease recognition and prognosis](https://scholariq.org/papers/classification-of-antineutrophil-cytoplasmic-autoantibody-vasculitides-the-role/)
- [Acute Exacerbation of Interstitial Pneumonia Other Than Idiopathic Pulmonary Fibrosis](https://scholariq.org/papers/acute-exacerbation-of-interstitial-pneumonia-other-than-idiopathic-pulmonary/)
- [Identification of a Novel Antibody Associated with Autoimmune Pancreatitis](https://scholariq.org/papers/identification-of-a-novel-antibody-associated-with-autoimmune-pancreatitis/)

## Topic primary papers

Showing 15 of 75.

- [2017 European League Against Rheumatism/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups](https://scholariq.org/papers/2017-european-league-against-rheumatism-american-college-of-rheumatology/)
- [Frequency of specific cancer types in dermatomyositis and polymyositis: a population-based study](https://scholariq.org/papers/frequency-of-specific-cancer-types-in-dermatomyositis-and-polymyositis-a/)
- [2017 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Adult and Juvenile Idiopathic Inflammatory Myopathies and Their Major Subgroups](https://scholariq.org/papers/2017-european-league-against-rheumatism-american-college-of-rheumatology-2/)
- [Polymyositis–Dermatomyositis-associated Interstitial Lung Disease](https://scholariq.org/papers/polymyositis-dermatomyositis-associated-interstitial-lung-disease/)
- [224th ENMC International Workshop:](https://scholariq.org/papers/224th-enmc-international-workshop/)
- [Measures of adult and juvenile dermatomyositis, polymyositis, and inclusion body myositis: Physician and Patient/Parent Global Activity, Manual Muscle Testing (MMT), Health Assessment Questionnaire (HAQ)/Childhood Health Assessment Questionnaire (C‐HAQ), Childhood Myositis Assessment Scale (CMAS), Myositis Disease Activity Assessment Tool (MDAAT), Disease Activity Score (DAS), Short Form 36 (SF‐36), Child Health Questionnaire (CHQ), Physician Global Damage, Myositis Damage Index (MDI), Quantitative Muscle Testing (QMT), Myositis Functional Index‐2 (FI‐2), Myositis Activities Profile (MAP), Inclusion Body Myositis Functional Rating Scale (IBMFRS), Cutaneous Dermatomyositis Disease Area and Severity Index (CDASI), Cutaneous Assessment Tool (CAT), Dermatomyositis Skin Severity Index (DSSI), Skindex, and Dermatology Life Quality Index (DLQI)](https://scholariq.org/papers/measures-of-adult-and-juvenile-dermatomyositis-polymyositis-and-inclusion-body/)
- [The diagnostic utility of anti-melanoma differentiation-associated gene 5 antibody testing for predicting the prognosis of Japanese patients with DM](https://scholariq.org/papers/the-diagnostic-utility-of-anti-melanoma-differentiation-associated-gene-5/)
- [239th ENMC International Workshop: Classification of dermatomyositis, Amsterdam, the Netherlands, 14–16 December 2018](https://scholariq.org/papers/239th-enmc-international-workshop-classification-of-dermatomyositis-amsterdam/)
- [Frequency, mutual exclusivity and clinical associations of myositis autoantibodies in a combined European cohort of idiopathic inflammatory myopathy patients](https://scholariq.org/papers/frequency-mutual-exclusivity-and-clinical-associations-of-myositis/)
- [Calcinosis cutis](https://scholariq.org/papers/calcinosis-cutis/)
- [Inclusion body myositis: current pathogenetic concepts and diagnostic and therapeutic approaches](https://scholariq.org/papers/inclusion-body-myositis-current-pathogenetic-concepts-and-diagnostic-and/)
- [Anti-NXP2 autoantibodies in adult patients with idiopathic inflammatory myopathies: possible association with malignancy](https://scholariq.org/papers/anti-nxp2-autoantibodies-in-adult-patients-with-idiopathic-inflammatory/)
- [Progressive myopathy with up-regulation of MHC-I associated with statin therapy](https://scholariq.org/papers/progressive-myopathy-with-up-regulation-of-mhc-i-associated-with-statin-therapy/)
- [Evaluation and construction of diagnostic criteria for inclusion body myositis](https://scholariq.org/papers/evaluation-and-construction-of-diagnostic-criteria-for-inclusion-body-myositis/)
- [Interstitial lung disease in patients with polymyositis, dermatomyositis and amyopathic dermatomyositis](https://scholariq.org/papers/interstitial-lung-disease-in-patients-with-polymyositis-dermatomyositis-and/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.